Novartis Investigative Site

Metz-Tessy 74370

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Heart Failure With Reduced Ejection Fraction (HF-rEF)

Studies at this site

• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE